In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism

Hypercoagulability is frequently observed in patients with severe coronavirus disease-2019 (COVID-19). Platelets are a favorable target for effectively treating hypercoagulability in COVID-19 patients as platelet hyperactivity has also been observed. It is difficult to develop a treatment for COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Quah, Yixian, Lee, Yuan Yee, Lee, Seung-Jin, Kim, Sung Dae, Rhee, Man Hee, Park, Seung-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482091/
https://www.ncbi.nlm.nih.gov/pubmed/36160270
http://dx.doi.org/10.1016/j.jgr.2022.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482091/
https://www.ncbi.nlm.nih.gov/pubmed/36160270
http://dx.doi.org/10.1016/j.jgr.2022.09.001

Ejemplares similares